Lipoprotein (a). Heterogeneity and biological relevance.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Clinical Investigation

• Publication date

  1990-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI114625PMID 2140835PMCID PMC296630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6

  2004cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Lipoprotein(a): structure, biology, and clinical relevance.

  1991cited by this paper
• Chapter 5 – Genetics of the Lp(a) Lipoprotein

  1990cited by this paper
• From phenotype to gene in common disorders

  1990cited by this paper
• Chapter 15 – Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels

  1990cited by this paper
• Lipoprotein(a), fibrin binding, and plasminogen activation.

  1990cited by this paper
• Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptor function.

  1990cited by this paper
• Chapter 4 – Structural Properties of Apo(a): A Major Apoprotein of Human Lipoprotein(a)

  1990cited by this paper
• Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a].

  1990cited by this paper
• Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons.

  1989cited by this paper
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

  1989cited by this paper
• A potential basis for the thrombotic risks associated with lipoprotein(a)

  1989cited by this paper
• Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

  1989cited by this paper
• Transient changes of serum lipoprotein(a) as an acute phase protein.

  1989cited by this paper
• Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation.

  1989cited by this paper
• Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen.

  1989cited by this paper
• Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.

  1989cited by this paper
• Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

  1989cited by this paper
• Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.

  1989cited by this paper
• Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.

  1989cited by this paper
• Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levels

  1989cited by this paper
• Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

  1989cited by this paper
• Lipoprotein(a) in nonhuman primates. Presence and characteristics of Lp(a) immunoreactive materials using anti-human Lp(a) serum.

  1989cited by this paper
• Production of lipoprotein(a) by primary baboon hepatocytes.

  1989cited by this paper
• Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis.

  1989cited by this paper
• Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

  1989cited by this paper
• Enzyme-linked immunoassay for Lp[a].

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.

  1988cited by this paper
• Lipoprotein (a) and plasminogen are immunochemically related.

  1988cited by this paper
• Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease.

  1988cited by this paper
• Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.

  1988cited by this paper
• In vivo studies on the binding sites for lipoprotein (a) on parenchymal and non‐parenchymal rat liver cells

  1988cited by this paper
• Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus).

  1988cited by this paper
• Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

  1988cited by this paper
• The apolipoprotein(a) gene resides on human chromosome 6q26–27, in close proximity to the homologous gene for plasminogen

  1988cited by this paper
• Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene.

  1988cited by this paper
• The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.

  1988cited by this paper
• Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions.

  1987cited by this paper
• Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.

  1986cited by this paper
• Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a).

  1986cited by this paper
• Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B

  1985cited by this paper
• Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

  1985cited by this paper
• Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

  1985cited by this paper
• A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis.

  1985cited by this paper
• Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

  1984cited by this paper
• Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

  1983cited by this paper
• Structural and Functional Changes of Rhesus Serum Low Density Lipoproteins During Cycles of Diet‐Induced Hypercholesterolemia

  1982cited by this paper
• Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts

  1981cited by this paper
• Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor

  1981cited by this paper
• Lipoprotein Lp(a) and the risk for myocardial infarction.

  1981cited by this paper
• Uptake of Lp (a) lipoprotein by cultured fibroblasts.

  1981cited by this paper
• Serum lipids in angiographically assessed coronary atherosclerosis.

  1978cited by this paper
• Radioimmunoassay of human plasma Lp(a) lipoprotein.

  1977cited by this paper
• Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease

  1975cited by this paper
• A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis.

  1974cited by this paper
• Studies on the heterogeneity of human serum Lp lipoproteins and on the occurrence of double Lp lipoprotein variants

  1973cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Lipoprotein (a) as a risk factor for prosthetic heart valve thrombosis

  2025cites this paper
• Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa

  2025cites this paper
• The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study

  2024cites this paper
• N-Acetylcysteine and Atherosclerosis: Promises and Challenges

  2023cites this paper
• Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role

  2022cites this paper
• Lipoprotein(a)

  2022cites this paper
• Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications

  2022cites this paper
• The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction.

  2021cites this paper
• The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study

  2020cites this paper
• The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests

  2020cites this paper
• Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype.

  2019cites this paper
• Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels.

  2019cites this paper
• Laboratory medicine: health evaluation in elite athletes

  2019cites this paper
• Evaluation of serum lipoproteins - A and its Association with Inflammatory Markers in Patients with Rheumatoid Arthritis

  2018cites this paper
• Lipoprotein(a): A missing culprit in the management of athero‐thrombosis?

  2018influential citation
• Kobe University Repository : Kernel タイトル Tit le The Relat ion of 5 ' flanking Region of the Apolipoprotein ( a ) Gene to Serum Lipoprotein ( a ) Level 著者

  2018cites this paper
• 9313 Evaluation of serum lipoproteins - A and its Association with Inflammatory Markers in Patients with Rheumatoid

  2018cites this paper
• Evaluation of serum lipoproteins - A and its Association with Inflammatory Markers in Patients with Rheumatoid Arthritis

  2018cites this paper
• Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis

  2017cites this paper
• Lipoprotein(a) and LDL-Cholesterol Status in type 2 Diabetes Mellitus with Microvascular Complications

  2017cites this paper
• Lipoprotein (a) Evolution: Possible Benefits and Harm. Genetic and Non-Genetic Factors Influencing its Plasma Levels.

  2017cites this paper
• Comparison of Fasting and Non Fasting Lipid Profile and Lipoprotein (a) in Healthy Adult Population

  2017cites this paper
• Interaction Between Vitamin D and Lipoprotein (a) on the Presence and Extent of Coronary Heart Disease.

  2017cites this paper
• Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes

  2017cites this paper
• Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels.

  2017cites this paper
• Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

  2016cites this paper
• The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk.

  2016cites this paper
• DIABETES AND INFLUENCE IN PROGRESS CHRONIC KIDNEY FAILURE

  2016cites this paper
• Lipoprotein(a)--An independent causal risk factor for cardiovascular disease and current therapeutic options.

  2015cites this paper
• Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases

  2015cites this paper
• CONCENTRATION OF APOLIPOPROTEIN-B 100 ( ApoB 100 ) and LIPOPROTEIN [ ( a ) Lp ( a ) ] AT PATIENTS WITH DIABETES MELLITUS 1

  2014cites this paper
• Review of Lipid and Lipoprotein(a) Abnormalities in Childhood Arterial Ischemic Stroke

  2014cites this paper
• Effects of Atorvastatin and Niacin, Alone and in Combination, On Lowering Serum LDL-Cholesterol and Lipoprotein (a) in Hyperlipidemia Patients

  2014cites this paper
• Therapeutic vaccines for hypertension and dyslipidemia.

  2014cites this paper
• EVALUATION OF SERUM LIPOPROTEINS - A AND ITS ASSOCIATION WITH INFLAMMATORY MARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS

  2014cites this paper
• Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.

  2014cites this paper
• The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins

  2014cites this paper
• Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a)

  2013cites this paper
• Transgenic Mice Expressing High Plasma Concentrations of Human Apolipoprotein B 100 and Lipoprotein ( a )

  2013cites this paper
• Hormonal Regulation of Serum Lp ( a ) Levels

  2013influential citation
• Lipoprotein(a) Oxidation, Autoimmune and Atherosclerosis

  2012cites this paper
• Niveles séricos de lipoproteína (a) en pacientes post infarto de miocardio

  2012cites this paper
• Effects of Treatment with Verapamil SR and Captopril on the Lipid Profile of Hypertensive Patients

  2012cites this paper
• LDL-Apheresis: Technical and Clinical Aspects

  2012cites this paper
• A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis

  2012cites this paper
• 2 Lipoprotein ( a ) Oxidation , Autoimmune and Atherosclerosis

  2012cites this paper
• Oxidized phospholipids modify plasminogen and apolipoprotein(a): Implications for vascular disease *

  2012cites this paper
• Tocotrienols as possible treatments for obesity

  2012cites this paper
• High-Density Lipoprotein Metabolism

  2011cites this paper
• Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity.

  2011cites this paper
• Lipoprotein(a)-cholesterol: a significant component of serum cholesterol.

  2011cites this paper
• Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus

  2011cites this paper
• Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation

  2011cites this paper
• Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.

  2010cites this paper
• Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease

  2010cites this paper
• Behçet's Disease as a Model of Venous Thrombosis.

  2010cites this paper
• Lp(a), Suatu Faktor Atherotrombotik

  2010cites this paper
• Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet

  2010cites this paper
• Behçet’s Disease as a Model of Venous Thrombosis

  2010cites this paper
• Lipoprotein ( a ) Lp ( a ) ELISA Enzyme Immunoassay for the Determination of Lipoprotein a [ Lp ( a ) ] in Human Serum , Citrate and EDTA Plasma

  2010cites this paper
• The Response-to-Retention Hypothesis of Early Atherogenesis

  2010cites this paper
• Plasma lipoproteins and coronary heart disease

  2010cites this paper
• Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful

  2009cites this paper
• Rheumatoid arthritis and thrombosis.

  2009cites this paper
• Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity

  2009cites this paper
• The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low‐density lipoproteins and are probably of cellular origin

  2009cites this paper
• Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.

  2009cites this paper
• Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.

  2009cites this paper
• Are advanced lipoprotein testing and subfractionation clinically useful

  2009cites this paper
• Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity

  2009cites this paper
• Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort

  2008cites this paper
• Serum Lp(a) in diabetics with and without evidence of clinical nephropathy—A preliminary study

  2008cites this paper
• Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.

  2008cites this paper
• Aterosklerotik Koroner Arter Hastalığında Bir Risk Göstergesi Olarak Lipoprotein (a)'nın Değeri THE VALUE OF LIPOPROTEIN(a) AS A PREDICTOR OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE

  2008cites this paper
• Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins.

  2007influential citation
• Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management

  2007cites this paper
• LPA +93C>T and +121G>A polymorphisms detection by electronic microchip technology.

  2007cites this paper
• Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies

  2007cites this paper
• Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.

  2007cites this paper
• The molecular nature and consequences of lipoprotein (a)'s association with platelets.

  2007cites this paper
• The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.

  2006cites this paper
• Epidemiologyof thrombotic-hemostaticfactorsand their associationswith cardiovasculardiseas&3

  2006cites this paper
• Lipoprotein(a): a unique risk factor for cardiovascular disease.

  2006cites this paper
• Lipids and atherosclerosis

  2006cites this paper
• Recent developments in the treatment of atherosclerosis

  2006cites this paper
• Serum lipoprotein (a) levels in patients with diabetic foot lesions.

  2006cites this paper
• Reduction of Serum L Prostatic Cancer poprotein ( a ) by Estrogen in Men with

  2006cites this paper
• 240 Glutamine / Histidine Polymorphism in Apo AIV Affects Plasma Concentrations of Lipoprotein ( a ) and Fibrin Split Products in Coronary Heart Disease Patients

  2005cites this paper
• Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500239-JLR200

  2005cites this paper
• Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage

  2005cites this paper
• Is Lipoprotein (a)—Apheresis Useful?

  2005cites this paper
• Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome

  2005cites this paper
• New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)

  2005cites this paper
• Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes

  2005cites this paper
• Lipoprotein (a) level in acute myocardial infarction: comparison with healthy subjects.

  2005cites this paper
• An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo

  2005cites this paper
• The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease.

  2005cites this paper
• Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

  2004cites this paper
• Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations?

  2004cites this paper
• A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

  2004cites this paper